What did @beingmarcellahill actually say?
The creator gave a two-and-a-half-month TRT update on her partner, describing a situation where his testosterone "shot through the roof" and is now "converting over to estrogen." She says high testosterone is "canceling out his anxiety meds and his depression meds," and that the clinical team plans to lower his testosterone dose and add "a blocker for estrogen." She also mentions incidental findings of high cholesterol on bloodwork.
To her credit, she frames TRT as a process rather than a quick fix: "it's not just one and done." She's describing a real clinical scenario, not a testimonial about miraculous results. That framing is more honest than most hormone content on TikTok. But some of the specific mechanistic claims deserve a closer look.
Does the science back this up?
The core biology here is largely accurate. Exogenous testosterone does convert to estradiol via aromatase, and supraphysiologic testosterone levels are a real and common problem in TRT management. Yes, elevated estradiol can cause symptoms, and aromatase inhibitors (AIs) are a legitimate clinical tool. But the claim that high testosterone is "canceling out" psychiatric medications is where things get oversimplified.
There is evidence that hormonal changes can affect pharmacodynamics of certain medications. A 2020 review in Psychoneuroendocrinology (McHenry et al.) noted that sex hormones influence serotonergic and dopaminergic systems. However, "canceling out" antidepressants or anxiolytics is not a documented pharmacological mechanism in the way she implies. What's more likely is that the hormonal dysregulation is producing symptoms, such as mood swings or anxiety, that are not being adequately addressed by current psychiatric dosing. Those are different things. The distinction matters clinically and for patients trying to understand their own treatment.
What did they get wrong (or right)?
They got several things right. Titration is real. Finding an optimal testosterone level varies significantly between individuals, and two to three months is a reasonable timeline to still be adjusting. The 2018 Journal of Clinical Endocrinology and Metabolism guidelines (Bhasin et al.) support individualized dosing and monitoring rather than fixed protocols. The mention of incidental cholesterol findings is also a genuine benefit of bloodwork monitoring, which is often overlooked in TRT discussions.
What they got wrong, or at least muddled:
- Testosterone does not pharmacologically "cancel" psychiatric medications. This is an imprecise description that could lead patients to blame their medications rather than address hormonal optimization properly.
- Describing the estrogen blocker as a straightforward fix understates the risks of aromatase inhibitors. AIs can suppress estradiol too aggressively, causing bone density loss, joint pain, and worsened lipid profiles. A 2017 study in The Journal of Clinical Endocrinology and Metabolism (Finkelstein et al.) found that estrogen plays an important role in male sexual function and body composition. Blocking it carelessly is not benign.
- The creator is not a clinician, and while she says he's working with a telehealth team, the way she explains the clinical reasoning could mislead viewers into self-diagnosing similar situations.
What should you actually know?
If you're a man on TRT and you're not feeling better after two to three months, the most important step is reviewing your actual lab values, not just testosterone total, but free testosterone, estradiol (E2), SHBG, hematocrit, and a full lipid panel. Supraphysiologic testosterone driving excess aromatization is a documented, manageable issue, but it requires careful lab interpretation, not just adding an AI automatically.
Aromatase inhibitors like anastrozole are sometimes used in TRT management, but they carry real risks and are not approved by the FDA specifically for this use in men. If a telehealth provider is recommending one, you should be asking what your E2 level actually is, not just whether your testosterone is high. The Endocrine Society recommends maintaining estradiol within a physiologic range rather than suppressing it outright.
On the psychiatric medication interaction point: if your mood symptoms are worsening on TRT, talk to both your prescribing clinician and your mental health provider. Hormonal changes can affect mood independently, and that conversation should happen across specialties, not be resolved by adjusting one variable in isolation.